Beta-cell destruction and preservation in childhood and adult onset type 1 diabetes

Endocrine

Volumn 49, Issue 3, 2015, Pages 693-702

  Poudel, Ananta ^a   Savari, Omid ^b   Striegel, Deborah A ^c   Periwal, Vipul ^c   Taxy, Jerome ^d   Millis, J Michael ^b   Witkowski, Piotr ^b   Atkinson, Mark A ^e   Hara, Manami ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b THE UNIVERSITY OF CHICAGO   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

Adult onset; Beta cells; Childhood onset; Pancreatic islets; Type 1 diabetes

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CELL COMPOSITION; CELL DAMAGE; CELL DEGENERATION; CELL LOSS; CELL POPULATION; CELLULAR DISTRIBUTION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIABETOGENESIS; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; ONSET AGE; ORGAN WEIGHT; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL DESTRUCTION; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS ISLET DELTA CELL; PANCREAS WEIGHT; PRIORITY JOURNAL; SCHOOL CHILD; FEMALE; INFANT; PANCREAS; PANCREAS FUNCTION TEST; PANCREAS ISLET BETA CELL; PATHOLOGY; SOMATOSTATIN CELL; ULTRASTRUCTURE;

ADULT; AGE OF ONSET; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON-SECRETING CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INSULIN-SECRETING CELLS; MALE; PANCREAS; PANCREATIC FUNCTION TESTS; SOMATOSTATIN-SECRETING CELLS;

EID: 84937978362     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0534-9     Document Type: Article

References (37)

1. M.A. Atkinson, G.S. Eisenbarth, A.W. Michels, Type 1 diabetes. Lancet 383, 69–82 (2014)
2. D. Dabelea, E.J. Mayer-Davis, S. Saydah, G. Imperatore, B. Linder, J. Divers, R. Bell, A. Badaru, J.W. Talton, T. Crume, A.D. Liese, A.T. Merchant, J.M. Lawrence, K. Reynolds, L. Dolan, L.L. Liu, R.F. Hamman, SEARCH for Diabetes in Youth Study, Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311, 1778–1786 (2014)
3. R.D. Leslie, Predicting adult-onset autoimmune diabetes: clarity from complexity. Diabetes 59, 330–331 (2010)
4. J. Karjalainen, P. Salmela, J. Ilonen, H.M. Surcel, M. Knip, A comparison of childhood and adult type I diabetes mellitus. N. Engl. J. Med. 320, 881–886 (1989)
5. A. Schiffrin, S. Suissa, G. Weitzner, P. Poussier, D. Lalla, Factors predicting course of beta-cell function in IDDM. Diabetes Care 15, 997–1001 (1992)
6. E. Sabbah, K. Savola, T. Ebeling, P. Kulmala, P. Vähäsalo, J. Ilonen, P.I. Salmela, M. Knip, Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 23, 1326–1332 (2000)
7. E.B. Tsai, N.A. Sherry, J.P. Palmer, K.C. Herold, The rise and fall of insulin secretion in type 1 diabetes mellitus. Diabetologia 49, 261–270 (2006)
8. M.P. Gallagher, R.S. Goland, C.J. Greenbaum, Making progress: preserving beta cells in type 1 diabetes. Ann. N. Y. Acad. Sci. 1243, 119–134 (2011)
9. S.R. Merger, R.D. Leslie, B.O. Boehm, The broad clinical phenotype of Type 1 diabetes at presentation. Diabetes Med. 30, 170–178 (2013)
10. D. Pipeleers, M. Chintinne, B. Denys, G. Martens, B. Keymeulen, F. Gorus, Restoring a functional beta-cell mass in diabetes. Diabetes Obes. Metab. 10(Suppl 4), 54–62 (2008)
11. S. Madsbad, O.K. Faber, C. Binder, P. McNair, C. Christiansen, I. Transbtfl, Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes. Diabetes 27(Suppl 1), 262–264 (1978)
12. The Diabetes Control and Complications Trial Research Group, Effects of age, duration and treatment of insulin dependent diabetes-mellitus on residual beta-cell function—observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J. Clin. Endocrinol. Metab. 65, 30–36 (1987)
13. The Diabetes Control and Complications Trial Research Group, Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial—a randomized, controlled trial. Ann. Intern. Med. 128, 517–523 (1998)
14. J.J. Meier, A. Bhushan, A.E. Butler, R.A. Rizza, P.C. Butler, Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48, 2221–2228 (2005)
15. K. Miller, A. Kim, G. Klimnik, J. Jo, U. Moka, V. Periwal, M. Hara, Islet formation during neonatal development. PLoS ONE 4, e7739 (2009)
16. A. Kim, G. Kilimnik, C. Guo, J. Sung, J. Jo, V. Periwal, P. Witkowski, P. Dilorio, M. Hara. Computer-assisted large-scale visualization and quantification of pancreatic islet mass, size distribution and architecture. J. Vis. Exp. 49, (2011). doi: 10.3791/2471
17. X. Wang, M.C. Zielinski, R. Misawa, P. Wen, T.Y. Wang, C.Z. Wang, P. Witkowski, M. Hara, Quantitative analysis of pancreatic polypeptide cell distribution in the human pancreas. PLoS ONE 8, e55501 (2013)
18. X. Wang, R. Misawa, M.C. Zielinski, P. Cowen, J. Jo, V. Periwal, C. Ricordi, A. Khan, J. Szust, J. Shen, J.M. Millis, P. Witkowski, M. Hara, Regional differences in islet distribution in the human pancreas–preferential beta-cell loss in the head region in patients with type 2 diabetes. PLoS ONE 8, e67454 (2013)
19. G. Kilimnik, J. Jo, V. Periwal, M.C. Zielinski, M. Hara, Quantification of islet size and architecture. Islets 4, 167–172 (2012)
20. M. Brissova, M.J. Fowler, W.E. Nicholson, A. Chu, B. Hirshberg, D.M. Harlan, A.C. Powers, Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 53, 1087–1097 (2005)
21. O. Cabrera, D.M. Berman, N.S. Kenyon, C. Ricordi, P.O. Berggren, A. Caicedo, The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U.S.A. 103, 2334–2339 (2006)
22. G. Kilimnik, B. Zhao, J. Jo, V. Periwal, P. Witkowski, R. Misawa, M. Hara, Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes. PLoS ONE 6, e27445 (2011)
23. R. Vracko, Basal lamina layering in diabetes mellitus. Evidence for accelerated rate of cell death and cell regeneration. Diabetes 23, 94–104 (1974)
24. K.L. Graham, R.M. Sutherland, S.I. Mannering, Y. Zhao, J. Chee, B. Krishnamurthy, H.E. Thomas, A.M. Lew, T.W. Kay, Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease. Rev. Diabetes Stud. 9, 148–168 (2012)
25. L. Ding, C. Gysemans, C. Mathieu, β-Cell differentiation and regeneration in type 1 diabetes. Diabetes Obes. Metab. 15(Suppl 3), 98–104 (2013)
26. K.M. Andralojc, A. Mercalli, K.W. Nowak, L. Albarello, R. Calcagno, L. Luzi, E. Bonifacio, C. Doglioni, L. Piemonti, Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia 52, 486–493 (2009)
27. A. Willcox, S.J. Richardson, A.J. Bone, A.K. Foulis, N.G. Morgan, Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173–181 (2009)
28. M.L. Campbell-Thompson, M.A. Atkinson, A.E. Butler, N.M. Chapman, G. Frisk, R. Gianani, B.N. Giepmans, M.G. von Herrath, H. Hyöty, T.W. Kay, O. Korsgren, N.G. Morgan, A.C. Powers, A. Pugliese, S.J. Richardson, P.A. Rowe, S. Tracy, P.A. In’t Veld, The diagnosis of insulitis in human type 1 diabetes. Diabetologia 56, 2541–2543 (2013)
29. J.C. Henquin, J. Rahier, Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia 54, 1720–1725 (2011)
30. J. Rahier, R.M. Goebbels, J.C. Henquin, Cellular composition of the human diabetic pancreas. Diabetologia 24, 366–371 (1983)
31. A. Clark, C.A. Wells, I.D. Buley, J.K. Cruickshank, R.I. Vanhegan, D.R. Matthews, G.J. Cooper, R.R. Holman, R.C. Turner, Islet amyloid, increased alpha-cells, reduced beta-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res. 9, 151–159 (1988)
32. K.H. Yoon, S.H. Ko, J.H. Cho, J.M. Lee, Y.B. Ahn, K.H. Song, S.J. Yoo, M.I. Kang, B.Y. Cha, K.W. Lee, H.Y. Son, S.K. Kang, H.S. Kim, I.K. Lee, S. Bonner-Weir, Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J. Clin. Endocrinol. Metab. 88, 2300–2308 (2003)
33. S.A. Greeley, R.N. Naylor, L.H. Philipson, G.I. Bell, Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr. Diabetes Rep. 11, 519–532 (2011)
34. N.A. Sherry, J.A. Kushner, M. Glandt, T. Kitamura, A.M. Brillantes, K.C. Herold, Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 55, 3238–3245 (2006)
35. R. Gianani, M. Campbell-Thompson, S.A. Sarkar, C. Wasserfall, A. Pugliese, J.M. Solis, S.C. Kent, B.J. Hering, E. West, A. Steck, S. Bonner-Weir, M.A. Atkinson, K. Coppieters, M. von Herrath, G.S. Eisenbarth, Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53, 690–698 (2010)
36. R. Kanakatti Shankar, C. Pihoker, L.M. Dolan, D. Standiford, A. Badaru, D. Dabelea, B. Rodriguez, M.H. Black, G. Imperatore, A. Hattersley, S. Ellard, L.K. Gilliam, SEARCH for Diabetes in Youth Study Group, Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for diabetes in youth study. Pediatr. Diabetes 14, 174–180 (2013)
37. C. Pihoker, L.K. Gilliam, S. Ellard, D. Dabelea, C. Davis, L.M. Dolan, C.J. Greenbaum, G. Imperatore, J.M. Lawrence, S.M. Marcovina, E. Mayer-Davis, B.L. Rodriguez, A.K. Steck, D.E. Williams, A.T. Hattersley, Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for diabetes in youth. J. Clin. Endocrinol. Metab. 98, 4055–4062 (2013)